Tris Pharma
Monmouth Junction
About Tris Pharma
Tris Pharma, Inc. is focuses on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $141.6M
- Last round: Grant (Aug 2023)
- Website: trispharma.com
- Phone: (732) 940-2800
Industries & Categories
Biotechnology, Life Science, Manufacturing, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/tris-pharma-41067 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.